Jon Price – Managing Director – Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
Copyright 2023 – Finance News Network
Source: Finance News Network
19 Sep 2022 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the advantages of the company's sodium alumina solid state batteries over lithium-ion batteries, and the roadmap ahead to commercialisation.
Read More16 June 2020 - Social Tree Global co-founders, Max Hannah and James Saward-Anderson share their top 5 hacks for harnessing the power of social media in financial services.
Read More03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief Commercial Officer, Dr Anthony Filippis, discuss Antisense's progress, attracting new talent to the company, and what drew Dr Filippis to the role.
Read More03 Dec 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market's record November month, expectations for 2021 and portfolio structuring.
Read More23 Apr 2021 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses the company's FY21 profit update and guidance.
Read More12 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Brett McNeill discuss the FY25 full-year results of Djerriwarrh Investments (ASX:DJW).
Read More25 March 2024 - Altech Batteries Limited (ASX:ATC) Managing Director Iggy Tan provides an update on the company, discussing funding pathways and the results of the DFS.
Read More16 Aug 2023 - Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Read More17 Sep 2019 - Tinybeans Limited (ASX:TNY) Founder & CEO, Eddie Geller discusses the company's FY19 results, growth users to its platform, new services and strategy.
Read More23 Sep 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses signs of market recovery, government support, coronavirus vaccines and small cap performance.
Read More
